Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | HGNC ID | DiseaseId | DiseaseName | Frequency | Onset | HGMD variants | ClinVar variants |
---|
HPO disease - gene - phenotype typical associations: |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0100514 | HP:0100514 | Abnormality of vitamin E metabolism | 0 | AKR1D1 CL E G H | 6718 | 388 | ORPHA:79303 | Congenital bile acid synthesis defect type 2 | | | | 62 | | |
HP:0100514 | HP:0100514 | Abnormality of vitamin E metabolism | 0 | APOB CL E G H | 338 | 603 | OMIM:615558 | Hypobetalipoproteinemia, familial, 1 | | | | 356 | | |
HP:0100514 | HP:0100514 | Abnormality of vitamin E metabolism | 0 | CYP7A1 CL E G H | 1581 | 2651 | ORPHA:209902 | Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency | HP:0040282 - Frequent | | | 11 | | |
HP:0100514 | HP:0100514 | Abnormality of vitamin E metabolism | 0 | DNAJC21 CL E G H | 134218 | 27030 | ORPHA:811 | Shwachman-Diamond syndrome | | | | 5 | | |
HP:0100514 | HP:0100514 | Abnormality of vitamin E metabolism | 0 | DZIP1L CL E G H | 199221 | 26551 | ORPHA:731 | Autosomal recessive polycystic kidney disease | | | | 4 | | |
HP:0100514 | HP:0100514 | Abnormality of vitamin E metabolism | 0 | EFL1 CL E G H | 79631 | 25789 | ORPHA:811 | Shwachman-Diamond syndrome | | | | 1 | | |
HP:0100514 | HP:0100514 | Abnormality of vitamin E metabolism | 0 | FOCAD CL E G H | 54914 | 23377 | OMIM:619991 | | | | | 3 | | |
HP:0100514 | HP:0100514 | Abnormality of vitamin E metabolism | 0 | GPR35 CL E G H | 2859 | 4492 | ORPHA:171 | Primary sclerosing cholangitis | | | | 2 | | |
HP:0100514 | HP:0100514 | Abnormality of vitamin E metabolism | 0 | MST1 CL E G H | 4485 | 7380 | ORPHA:171 | Primary sclerosing cholangitis | | | | 1 | | |
HP:0100514 | HP:0100514 | Abnormality of vitamin E metabolism | 0 | MTTP CL E G H | 4547 | 7467 | ORPHA:14 | Abetalipoproteinemia | | | | 81 | | |
HP:0100514 | HP:0100514 | Abnormality of vitamin E metabolism | 0 | PKHD1 CL E G H | 5314 | 9016 | ORPHA:731 | Autosomal recessive polycystic kidney disease | | | | 563 | | |
HP:0100514 | HP:0100514 | Abnormality of vitamin E metabolism | 0 | SBDS CL E G H | 51119 | 19440 | ORPHA:811 | Shwachman-Diamond syndrome | | | | 26 | | |
HP:0100514 | HP:0100514 | Abnormality of vitamin E metabolism | 0 | SEMA4D CL E G H | 10507 | 10732 | ORPHA:171 | Primary sclerosing cholangitis | | | | | | |
HP:0100514 | HP:0100514 | Abnormality of vitamin E metabolism | 0 | SLC30A10 CL E G H | 55532 | 25355 | ORPHA:309854 | Cirrhosis-dystonia-polycythemia-hypermanganesemia syndrome | | | | 42 | | |
HP:0100514 | HP:0100514 | Abnormality of vitamin E metabolism | 0 | SLC51B CL E G H | 123264 | 29956 | OMIM:619481 | BILE ACID MALABSORPTION, PRIMARY, 2; PBAM2 | | | | | | |
HP:0100514 | HP:0100514 | Abnormality of vitamin E metabolism | 0 | SRP54 CL E G H | 6729 | 11301 | ORPHA:811 | Shwachman-Diamond syndrome | | | | | | |
HP:0100514 | HP:0100514 | Abnormality of vitamin E metabolism | 0 | TCF4 CL E G H | 6925 | 11634 | ORPHA:171 | Primary sclerosing cholangitis | | | | 241 | | |
HP:0100514 | HP:0100514 | Abnormality of vitamin E metabolism | 0 | TTPA CL E G H | 7274 | 12404 | OMIM:277460 | VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF | | | | 62 | | |
HP:0100514 | HP:0100513 | Low levels of vitamin E | 1 | AKR1D1 CL E G H | 6718 | 388 | ORPHA:79303 | Congenital bile acid synthesis defect type 2 | | | | 62 | | |
HP:0100514 | HP:0100513 | Low levels of vitamin E | 1 | APOB CL E G H | 338 | 603 | OMIM:615558 | Hypobetalipoproteinemia, familial, 1 | | | | 356 | | |
HP:0100514 | HP:0100513 | Low levels of vitamin E | 1 | DNAJC21 CL E G H | 134218 | 27030 | ORPHA:811 | Shwachman-Diamond syndrome | HP:0040282 - Frequent | | | 5 | | |
HP:0100514 | HP:0100513 | Low levels of vitamin E | 1 | DZIP1L CL E G H | 199221 | 26551 | ORPHA:731 | Autosomal recessive polycystic kidney disease | HP:0040282 - Frequent | | | 4 | | |
HP:0100514 | HP:0100513 | Low levels of vitamin E | 1 | EFL1 CL E G H | 79631 | 25789 | ORPHA:811 | Shwachman-Diamond syndrome | HP:0040282 - Frequent | | | 1 | | |
HP:0100514 | HP:0100513 | Low levels of vitamin E | 1 | FOCAD CL E G H | 54914 | 23377 | OMIM:619991 | | | | | 3 | | |
HP:0100514 | HP:0100513 | Low levels of vitamin E | 1 | GPR35 CL E G H | 2859 | 4492 | ORPHA:171 | Primary sclerosing cholangitis | HP:0040283 - Occasional | | | 2 | | |
HP:0100514 | HP:0100513 | Low levels of vitamin E | 1 | MST1 CL E G H | 4485 | 7380 | ORPHA:171 | Primary sclerosing cholangitis | HP:0040283 - Occasional | | | 1 | | |
HP:0100514 | HP:0100513 | Low levels of vitamin E | 1 | MTTP CL E G H | 4547 | 7467 | ORPHA:14 | Abetalipoproteinemia | HP:0040281 - Very frequent | | | 81 | | |
HP:0100514 | HP:0100513 | Low levels of vitamin E | 1 | PKHD1 CL E G H | 5314 | 9016 | ORPHA:731 | Autosomal recessive polycystic kidney disease | HP:0040282 - Frequent | | | 563 | | |
HP:0100514 | HP:0100513 | Low levels of vitamin E | 1 | SBDS CL E G H | 51119 | 19440 | ORPHA:811 | Shwachman-Diamond syndrome | HP:0040282 - Frequent | | | 26 | | |
HP:0100514 | HP:0100513 | Low levels of vitamin E | 1 | SEMA4D CL E G H | 10507 | 10732 | ORPHA:171 | Primary sclerosing cholangitis | HP:0040283 - Occasional | | | | | |
HP:0100514 | HP:0100513 | Low levels of vitamin E | 1 | SLC30A10 CL E G H | 55532 | 25355 | ORPHA:309854 | Cirrhosis-dystonia-polycythemia-hypermanganesemia syndrome | HP:0040283 - Occasional | | | 42 | | |
HP:0100514 | HP:0100513 | Low levels of vitamin E | 1 | SLC51B CL E G H | 123264 | 29956 | OMIM:619481 | BILE ACID MALABSORPTION, PRIMARY, 2; PBAM2 | | | | | | |
HP:0100514 | HP:0100513 | Low levels of vitamin E | 1 | SRP54 CL E G H | 6729 | 11301 | ORPHA:811 | Shwachman-Diamond syndrome | HP:0040282 - Frequent | | | | | |
HP:0100514 | HP:0100513 | Low levels of vitamin E | 1 | TCF4 CL E G H | 6925 | 11634 | ORPHA:171 | Primary sclerosing cholangitis | HP:0040283 - Occasional | | | 241 | | |
HP:0100514 | HP:0100513 | Low levels of vitamin E | 1 | TTPA CL E G H | 7274 | 12404 | OMIM:277460 | VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF | . | | | 62 | | |